• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

Introduction to Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate (CAS No. 628308-67-8)

Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate, with the chemical identifier CAS No. 628308-67-8, is a specialized compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedicine. This compound, featuring a complex structure that includes both protective and functional groups, plays a crucial role in the synthesis of various pharmacologically active molecules. Its unique chemical properties make it a valuable intermediate in the development of novel therapeutic agents.

The structure of Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate consists of an acetate backbone modified with a tert-butoxy carbonyl group and a 2-hydroxyethylamino side chain. The tert-butoxy carbonyl (Boc) group is widely used in organic synthesis as a protecting group for amine functionalities, ensuring that the amine remains unreactive under various conditions until it is selectively deprotected. This protective mechanism is essential in multi-step synthetic routes where selective reactions are required to achieve the desired product without unwanted side reactions.

The presence of the 2-hydroxyethylamino group adds another layer of functionality to the molecule, making it a versatile building block for the synthesis of more complex structures. This group can participate in various chemical reactions, including nucleophilic substitutions, condensations, and couplings, which are fundamental to constructing intricate molecular frameworks. The hydroxyl moiety within this group also introduces the possibility of further derivatization, allowing chemists to tailor the properties of the final product to meet specific requirements.

In recent years, Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate has been explored in several cutting-edge research areas. One notable application is in the development of peptidomimetics, which are synthetic molecules designed to mimic the biological activity of natural peptides but with improved stability and pharmacokinetic properties. The Boc-protected amine group provides a stable handle for solid-phase peptide synthesis (SPPS), enabling the efficient construction of peptide analogs. Additionally, the 2-hydroxyethylamino group can be used to introduce specific conformations or interactions into the peptidomimetic backbone, enhancing its binding affinity and selectivity.

The compound has also found utility in the synthesis of small-molecule inhibitors targeting enzyme active sites. Enzyme inhibition is a cornerstone of modern drug design, and compounds like Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate provide valuable scaffolds for developing inhibitors with high potency and specificity. The Boc protection ensures that reactive amine groups are shielded during initial synthetic steps, allowing chemists to focus on optimizing other parts of the molecule. Once the desired structure is achieved, selective deprotection under mild conditions yields the final active compound.

Advances in computational chemistry have further enhanced the utility of Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate. Molecular modeling studies have shown that this compound can adopt multiple conformations depending on its environment, providing insights into its reactivity and potential interactions with biological targets. These studies have been instrumental in guiding synthetic strategies and predicting the behavior of derived compounds in vitro and in vivo. By leveraging computational tools, researchers can accelerate the discovery process and reduce experimental trial-and-error.

The pharmaceutical industry has also recognized the potential of Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate as a key intermediate in drug development pipelines. Its structural features make it suitable for generating libraries of diverse compounds for high-throughput screening (HTS). HTS is a critical technique for identifying lead compounds with promising biological activity before further optimization. The ability to efficiently synthesize derivatives of Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate allows for rapid exploration of chemical space, increasing the likelihood of discovering novel therapeutics.

In conclusion, Ethyl 2-{(tert-butoxy)carbonyl(2-hydroxyethyl)amino}acetate (CAS No. 628308-67-8) is a multifaceted compound with significant applications in pharmaceutical chemistry and biomedicine. Its unique structural features enable its use as a versatile intermediate in synthetic routes leading to peptidomimetics and enzyme inhibitors. With ongoing advancements in computational chemistry and drug discovery methodologies, this compound continues to play a vital role in developing innovative therapeutic agents that address unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)